Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125733791 | 12573379 | 1 | I | 20160604 | 0 | 20160719 | 20160719 | DIR | 24.00 | YR | M | N | 125.00000 | LBS | 20160718 | N | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125733791 | 12573379 | 1 | PS | LAMICTAL | LAMOTRIGINE | 1 | Oral | 1 TABLET(S) IN THE MORNING TAKEN BY MOUTH | N | D | 0 | 1 | DF | COATED TABLET | |||||
125733791 | 12573379 | 3 | C | LEXAPRO | ESCITALOPRAM OXALATE | 1 | 0 | ||||||||||||
125733791 | 12573379 | 5 | C | KLONOPIN | CLONAZEPAM | 1 | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125733791 | 12573379 | 1 | Bipolar II disorder |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125733791 | 12573379 | LT |
125733791 | 12573379 | HO |
125733791 | 12573379 | DS |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125733791 | 12573379 | Drug withdrawal syndrome | |
125733791 | 12573379 | Lymphadenopathy | |
125733791 | 12573379 | Mouth swelling | |
125733791 | 12573379 | Myoclonus | |
125733791 | 12573379 | Pyrexia | |
125733791 | 12573379 | Rash |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
125733791 | 12573379 | 1 | 20160501 | 20160701 | 0 |